Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Allergan Plc (AGN US)
Watchlist
90
Analysis
Health Care
•
United States
Allergan plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Allergan offers its pharmaceutical drugs around the world.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Naspers
•
01 Sep 2019 08:20
Last Week in Event SPACE: Naspers, Toyota, Askul, Aveo, Maanshan, Autech, Olympus, Abbvie/Allergan
Last Week in Event SPACE ... Prosus (PRX NA) should trade at a premium to Naspers (NPN SJ) (ignoring the tiny economic shrapnel of the S.A....
David Blennerhassett
Follow
718 Views
Share
bullish
•
Allergan Plc
•
31 Aug 2019 08:47
Allergan Plc Acquisition by AbbVie Inc. – A Botox Deal with Some Wrinkles
On June 25, 2019, Abbvie Inc (ABBV US) announced its acquisition of Botox-maker Allergan Plc (AGN US) in a $63 billion cash and stock deal in which...
John DeMasi
Follow
892 Views
Share
bearish
•
Daewoong Pharmaceutical Co
•
28 Mar 2019 07:36
Daewoong: Entering "Botox World"
Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...
Kemp Dolliver, CFA
690 Views
Share
bullish
•
Sosei Group
•
26 Sep 2018 21:03
Investment Thesis and Valuation
Key Drivers Royalty from Seebri / Ultibro and QVM149 (expected launch in FY20e) to peak at ¥ 4.86b in FY25e Majority of the potential milestones...
Dion Stéfan Büchner M.D., FCAP
558 Views
Share
bullish
•
FamilyMart Co Ltd
•
21 Apr 2018 21:33
Last Week in Event SPACE: FamilyMart, Hyundai Motor Prefs, Renault/Nissan, Fortis Health, Korea Zinc
Last Week in Event SPACE ... FamilyMart UNY Holdings Co Ltd (8028 JP) has been in the sweet spot for post-merger synergies, however once Itochu...
David Blennerhassett
Follow
383 Views
Share
First
Previous
11
12
13
14
15
16
17
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x